-transparent.png){kind=logo}
In an effort to achieve high concentrations and prolonged exposure times, high-dose methotrexate (MTX) was administered by the intra-arterial route over 6 hours at a dose of 12.5 g/m2 to nine patients with osteosarcoma. This was followed by citrovorum factor (CF) rescue, which was initiated 12 hours after completion of the infusion (MTX-CF). The regimen achieved high local concentrations over a finite period. No toxicity was encountered. Treatment was administered at weekly intervals, during which intravenous MTX-CF was interposed if facilities for intra-arterial administration were not available. However, despite increases in local venous concentrations and exposure times, only four of nine patients (44%) responded. This is similar to responses achieved with 7.5 g/m2 (48%) with CF initiated 2 hours after completion of the infusion. Higher MTX doses, intra-arterial administration, and prolongation of cytotoxic exposure time did not confer a therapeutic advantage as opposed to "conventional" intravenous high doses.
N Jaffe, and
J Prudich, and
J Knapp, and
Y M Wang, and
R Bowman, and
A Cangir, and
A Ayala, and
V Chuang, and
S Wallace
August 1985,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
N Jaffe, and
J Prudich, and
J Knapp, and
Y M Wang, and
R Bowman, and
A Cangir, and
A Ayala, and
V Chuang, and
S Wallace
August 1994,
Journal of internal medicine,
N Jaffe, and
J Prudich, and
J Knapp, and
Y M Wang, and
R Bowman, and
A Cangir, and
A Ayala, and
V Chuang, and
S Wallace
February 1996,
Journal of chemotherapy (Florence, Italy),
N Jaffe, and
J Prudich, and
J Knapp, and
Y M Wang, and
R Bowman, and
A Cangir, and
A Ayala, and
V Chuang, and
S Wallace
June 1992,
Journal of chemotherapy (Florence, Italy),
N Jaffe, and
J Prudich, and
J Knapp, and
Y M Wang, and
R Bowman, and
A Cangir, and
A Ayala, and
V Chuang, and
S Wallace
February 2017,
Oncotarget,
N Jaffe, and
J Prudich, and
J Knapp, and
Y M Wang, and
R Bowman, and
A Cangir, and
A Ayala, and
V Chuang, and
S Wallace
January 1985,
AJR. American journal of roentgenology,
N Jaffe, and
J Prudich, and
J Knapp, and
Y M Wang, and
R Bowman, and
A Cangir, and
A Ayala, and
V Chuang, and
S Wallace
February 2009,
Therapeutic drug monitoring,
N Jaffe, and
J Prudich, and
J Knapp, and
Y M Wang, and
R Bowman, and
A Cangir, and
A Ayala, and
V Chuang, and
S Wallace
August 1990,
Gan to kagaku ryoho. Cancer & chemotherapy,
N Jaffe, and
J Prudich, and
J Knapp, and
Y M Wang, and
R Bowman, and
A Cangir, and
A Ayala, and
V Chuang, and
S Wallace
December 2001,
The Annals of pharmacotherapy,
N Jaffe, and
J Prudich, and
J Knapp, and
Y M Wang, and
R Bowman, and
A Cangir, and
A Ayala, and
V Chuang, and
S Wallace
December 2008,
The Lancet. Oncology,
